MCRB – seres therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare Conference [Yahoo! Finance]
Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare Conference
FDA Grants Breakthrough Therapy Designation to Seres Therapeutics' SER-155 for Reduction of Bloodstream Infections in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) [Yahoo! Finance]
FDA Grants Breakthrough Therapy Designation to Seres Therapeutics’ SER-155 for Reduction of Bloodstream Infections in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)
Seres Therapeutics, Inc. (NASDAQ: MCRB) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Form 4 Seres Therapeutics, Inc. For: Nov 15 Filed by: DesRosier Thomas
Form 4 Seres Therapeutics, Inc. For: Nov 15 Filed by: von Moltke Lisa
Form 4 Seres Therapeutics, Inc. For: Nov 15 Filed by: Shaff Eric D.
Form 4 Seres Therapeutics, Inc. For: Nov 15 Filed by: Young Teresa L.
Form 4 Seres Therapeutics, Inc. For: Nov 15 Filed by: Henn Matthew R.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.